Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07310537

Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling

Sponsor: Erasmus Medical Center

View on ClinicalTrials.gov

Summary

The goal of this observational study is to investigate whether circulating tumor-derived DNA (ctDNA) can be reliably detected and analyzed in blood obtained through automated capillary sampling in adult patients (≥21 years) with colorectal liver metastases (CRLM). The main question it aims to answer is: * Can ctDNA be detected in small volumes of capillary blood collected using an automated sampling device? * Do ctDNA levels measured in capillary blood agree with those measured in venous blood from the same patients? Researchers will compare ctDNA measurements from capillary blood to those from venous blood (reference standard) to see if capillary sampling provides reliable results for ctDNA analysis. Participants will: * Provide a small blood sample through automated capillary collection. * Provide a venous blood sample during the same study visit for comparison.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

OBSERVATIONAL

Enrollment

35

Start Date

2025-11-17

Completion Date

2027-11

Last Updated

2026-01-06

Healthy Volunteers

Not specified

Interventions

OTHER

Blood Collection - TAP® Device

K2EDTA BD Microtainer

OTHER

Blood Collection - Venous

10 mL EDTA Collection Tube

Locations (1)

Erasmus MC University Medical Center

Rotterdam, South Holland, Netherlands